Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Eureka Prima Jakarta Tbk. (LCGP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Eureka Prima Jakarta Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Eureka Prima Jakarta Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Eureka Prima Jakarta Tbk. diperdagangkan di Rp114 (kapitalisasi pasar 641,82 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Eureka Prima Jakarta Tbk. jauh lebih besar — sekitar 3,9× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

LCGPOBAT
Kapitalisasi Pasar
641,82 M166,01 M
Volume
324 rb
Lot
3,24 rb
Perputaran
77,68 jt
Harga Rata-rata
239,75
Nilai Transaksi
77,68 jt
Harga Ekuilibrium Indikatif
240
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

OBAT
Lihat detail

Tentang Eureka Prima Jakarta Tbk.

PT Eureka Prima Jakarta Tbk formerly Laguna Cipta Griya Tbk (the company) was established based on notarial deed No. 97 dated May 17, 20014 of Bambang Suwondo, S.H., notary in Jakarta and has been amended based on the deed No. 4 dated June 4, 2004 before notary H. Yunardi, S.H. The Company’s articles of association has been amended several times, most recently by notarial deed No. 40 of Fathiah Helmi, S.H., dated Jan 30, 2007, concerning among others, change the company's name.

Selengkapnya di halaman LCGP

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT